These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22374457)

  • 1. NSAID-PPI enteropathy in humans.
    Daniell HW
    Gastroenterology; 2012 Apr; 142(4):e20; author reply e20-1. PubMed ID: 22374457
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
    Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
    Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of contractile activity in the small intestine by indomethacin and omeprazole.
    Lichtenberger LM; Bhattarai D; Phan TM; Dial EJ; Uray K
    Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G785-93. PubMed ID: 25721304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
    Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
    J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAID-induced enteropathy: the current state of the problem.
    Svistunov AA; Osadchuk MA; Kireeva NV; Hudarova AA; Achkasov EE
    Ter Arkh; 2018 Aug; 90(8):95-100. PubMed ID: 30701943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAID and PUD complications.
    Sung J
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():60. PubMed ID: 15146799
    [No Abstract]   [Full Text] [Related]  

  • 8. Observational studies on prescription practices: interpret with caution.
    Savarino V; Dulbecco P
    Dig Liver Dis; 2010 May; 42(5):348-9. PubMed ID: 20356810
    [No Abstract]   [Full Text] [Related]  

  • 9. NSAID association with gastrointestinal bleeding and peptic ulcer.
    Hirschowitz BI; Lanas A
    Agents Actions Suppl; 1991; 35():93-101. PubMed ID: 1781426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.
    Ann Intern Med; 2010 Jan; 152(1):I-20. PubMed ID: 19949137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proton pump inhibitor H2 receptor antagonist].
    Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
    Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):11-16. PubMed ID: 27986133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-NSAID/aspirin interaction in peptic ulcer disease.
    Hunt RH; Yuan Y
    Dig Dis; 2011; 29(5):465-8. PubMed ID: 22095011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
    Ong TZ; Hawkey CJ; Ho KY
    J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
    Shimada T; Yamagata M; Hiraishi H
    Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.
    Ibáñez L; Vidal X; Laporte JR
    Am J Gastroenterol; 2008 Oct; 103(10):2658-9. PubMed ID: 18855866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.